Get the Weekly Intelligence Brief — top committee picks every Sunday.

CVSA vs DAR

Covista Inc. vs Darling Ingredients — AI-powered side-by-side comparison
CVSA
Covista Inc.
57
Watch
VS
DAR
Darling Ingredients
66
Buy
MetricCVSADAR
AI Score 57 66
Price $125.97 $62.38
P/E Ratio 16.60× 16.54×
ROE 17.4% 1.3%
Revenue Growth YoY
Gross Margin 57.3% 25.0%
Debt / Equity 0.63× 0.80×
Dividend Yield 0.0% 0.0%
RSI (14) 48.4 60.9
Beta 0.623 1.019
Expected Upside +5.1%

AI Committee View

Current Innellis committee reasoning for CVSA versus DAR.
DAR leads by 9 points.

DAR scores 66/100 (Buy) versus CVSA at 57/100 (Watch).

CVSA Committee View
50% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — current ratio of 0.82 is tight -- limited short-term liquidity cushion. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • ROE of 16.6% shows genuine earnings power backing the valuation — Value
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
  • Current ratio of 0.82 is tight -- limited short-term liquidity cushion — Risk
  • Bollinger bandwidth of 24.6% signals elevated volatility — Risk
DAR Committee View
60% agreement
5 analysts

Positive signals support the current rating — eps growing 470.4% yoy. The committee sees sufficient evidence to maintain the constructive view.

Bull Case
  • Price-to-book of 1.3x is a discount to asset value — Value
  • EPS growing 470.4% YoY — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
  • ROE of only 4.7% -- cheap may mean cheap for a reason — Value
  • MACD histogram negative -- bearish momentum — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
CVSA Full Analysis DAR Full Analysis